Amstrin Pharma Pvt Ltd
About Amstrin Pharma Pvt Ltd
Data last updated:
Amstrin Pharma Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 April 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1987PTC043234. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹62.51 Lakh. It is led by directors Girish Vadilal Shah and Raj Girish Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.13/D Kurla Industrial Estate Nari Seva Sadan Road Ghatjkopar (West), Mumbai, Maharashtra, India – 400086.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.36 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹12.27 Lakh (net margin 44.9%) and EBITDA of ₹22.93 Lakh (EBITDA margin 83.8%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 23% over five years.
As per MCA filings, the company has satisfied charges of ₹2.1 Cr on record. Court records list 3 cases involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.13/D Kurla Industrial Estate Nari Seva Sadan Road Ghatjkopar (West), Mumbai, Maharashtra, India – 400086
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Amstrin Pharma Pvt Ltd FY 2025 filings available
Amstrin Pharma Pvt Ltd reported revenue of ₹27.36 Lakh (down 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Amstrin Pharma Pvt Ltd
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 23%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Amstrin Pharma Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹22.93 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.27 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Amstrin Pharma Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 83.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 44.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amstrin Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Amstrin Pharma Pvt Ltd
Amstrin Pharma Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adertis Healthmark Private Limited | ₹27.59 Lakh (FY 2025) | •••• | •••• | 169.0% | •••• | Ambala, Haryana, India |
| Stericure Pharmaceuticals Private Limited | ₹27.55 Lakh (FY 2021) | •••• | •••• | 1181.0% | •••• | Puducherry, India |
| GPR Life Sciences Private Limited | ₹27.5 Lakh (FY 2025) | •••• | •••• | 1442.0% | •••• | Hyderabad, Telangana, India |
| Capillon Pharma Private Limited | ₹27.47 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Baddi, Himachal Pradesh, India |
| Livestar Pharmaceuticals Private Limited | ₹27.37 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Delhi, India |
| Amstrin Pharma Pvt Ltd this company | ₹27.36 Lakh (FY 2024) | •••• | •••• | -6.0% | •••• | Mumbai, Maharashtra, India |
| Gebot Biotech Private Limited | ₹27.36 Lakh (FY 2016) | •••• | •••• | -14.0% | •••• | Bhopal, Madhya Pradesh, India |
| PSP Research India Private Limited | ₹27.25 Lakh (FY 2024) | •••• | •••• | -50.0% | •••• | Chandigarh, India |
| Gouri Healthcare and Pharmaceutical Private Limited | ₹27.21 Lakh (FY 2025) | •••• | •••• | •••• | Sangli, Maharashtra, India | |
| Intellicus Life Science Private Limited | ₹27.2 Lakh (FY 2025) | •••• | •••• | 195.0% | •••• | Nagpur, Maharashtra, India |
| Navkem Healthcare Limited | ₹26.97 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Howrah, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Amstrin Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Amstrin Pharma Pvt Ltd
Amstrin Pharma Pvt Ltd is audited by K S N C & CO LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K S N C & CO LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Amstrin Pharma Pvt Ltd
Amstrin Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Vadilal Shah | Director | 09 Jun 2009 | 17 Years 3 Months | Current |
| Raj Girish Shah | Director | 03 Aug 2019 | 7 Years 2 Months | Current |
Ownership and Shareholding of Amstrin Pharma Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Amstrin Pharma Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 1998 | State Bank of India | ₹76.2 Lakh | Satisfied |
| 29 Jul 1997 | State Bank of India | ₹50 Lakh | Satisfied |
| 13 May 1995 | State Bank of India | ₹25 Lakh | Satisfied |
| 26 Jul 1990 | State Bank of India | ₹58.7 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Amstrin Pharma Pvt Ltd
Amstrin Pharma Pvt Ltd has 3 court cases on record: 1 filed against it, 2 where it is another party. 1 case is pending and 2 are disposed. Status as checked between 30 Sep 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nashik, Maharashtra | Court case (R.C.C.) | Company is another party | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Omkar Traders | Disposed |
| District court, Amravati, Maharashtra | Court case (R.C.C.) | Company is another party | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Amstrin Pharma Pvt Ltd
Amstrin Pharma Pvt Ltd has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 2 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| KJB & Co LLP | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Amstrin Pharma Pvt Ltd
Employment history and EPFO contributions of people linked to Amstrin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Amstrin Pharma Pvt Ltd
Amstrin Pharma Pvt Ltd has 7 board changes on record since 2009: 2 appointments and 5 cessations. The latest: Jayantilal Vadilal Shah ceased to be Director on 23 Mar 2022.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Amstrin Pharma Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Amstrin Pharma Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Amstrin Pharma Pvt Ltd
Amstrin Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Amstrin Pharma Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amstrin Pharma Pvt Ltd
Amstrin Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 April 1987 (39+ years old) and is registered under CIN U24239MH1987PTC043234.
Amstrin Pharma reported revenue of ₹27.36 Lakh for FY 2024 (down 6% YoY).
Amstrin Pharma has 2 current directors:
- Girish Vadilal Shah - Director
- Raj Girish Shah - Director
Amstrin Pharma reported a net profit of ₹12.27 Lakh (net margin 44.9%) and EBITDA of ₹22.93 Lakh (EBITDA margin 83.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Amstrin Pharma is 15% over three years and 23% over five years. In the latest year (FY 2024) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
No. Amstrin Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Amstrin Pharma is U24239MH1987PTC043234. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amstrin Pharma has 3 court cases on record: 1 filed against it. 1 is pending.
Amstrin Pharma was incorporated on 23 April 1987, making it 39+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Amstrin Pharma by revenue are Adertis Healthmark Private Limited, Stericure Pharmaceuticals Private Limited, GPR Life Sciences Private Limited, Capillon Pharma Private Limited, Livestar Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Jayantilal Vadilal Shah ceased to be Director on 23 Mar 2022. Raj Girish Shah ceased to be Additional Director on 30 Sep 2019. Raj Girish Shah was appointed as Director on 03 Aug 2019. Amstrin Pharma has 7 board changes on record in total.
Amstrin Pharma has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 2 overdue payments to 1 micro and small supplier. The latest return was filed on 13 May 2021.